Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$0.6 - $1.14 $30,000 - $56,999
50,000 Added 52.63%
145,000 $91,000
Q4 2022

Feb 14, 2023

BUY
$1.25 - $65.2 $87,500 - $4.56 Million
70,000 Added 280.0%
95,000 $133,000
Q3 2022

Nov 14, 2022

BUY
$1.33 - $21.7 $33,250 - $542,500
25,000 New
25,000 $54,000

Others Institutions Holding SNTI

About Senti Biosciences, Inc.


  • Ticker SNTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,757,100
  • Market Cap $172M
  • Description
  • Senti Biosciences, Inc. operates as a gene circuit company. The company develops cell and gene therapies engineered with gene circuits that are designed to reprogram cells with biological logic to sense inputs, compute decisions, and respond to respective cellular environments. Its synthetic biology platform utilizes off-the-shelf chimeric antig...
More about SNTI
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.